Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

Maju Mathews,1 Srihari Gopal,1 Isaac Nuamah,1 Ludger Hargarter,2 Adam J Savitz,1 Edward Kim,3 Wilson Tan,4 Bernardo Soares,5 Christoph U Correll6–81Department of Neuroscience, Janssen Research & Development, LLC, Raritan, NJ, USA; 2Department of Neuroscience, Janssen-Cilag EMEA, Ne...

Full description

Bibliographic Details
Main Authors: Mathews M, Gopal S, Nuamah I, Hargarter L, Savitz AJ, Kim E, Tan W, Soares B, Correll CU
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
number-needed-to-harm
number-needed-to-treat
paliperidone palmitate 3-monthly
remission
Online Access:https://www.dovepress.com/clinical-relevance-of-paliperidone-palmitate-3-monthly-in-treating-sch-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/clinical-relevance-of-paliperidone-palmitate-3-monthly-in-treating-sch-peer-reviewed-article-NDT

Similar Items